What are the side effects of Itovebi (inavolisib)-u200c inalise

Itovebi (inavolisib) is an innovative anti-cancer drug for the treatment of breast cancer. It exerts its key role in anti-cancer therapy by acting as an inhibitor and degrader of mutant phosphatidylinositol 3-kinase (PI3K) alpha. The PI3K-mediated signaling pathway plays a crucial role in the development of tumors, and its dysregulation is often closely related to tumor growth and resistance to anti-tumor drugs and radiotherapy.

During the clinical application of Itovebi, patients may experience a series of adverse reactions. Among them, the more common ones include stomatitis, which manifests as inflammation and discomfort of the oral mucosa; diarrhea, which may cause an imbalance of the patient's body fluids and electrolytes; fatigue, which affects the patient's quality of daily life; nausea, which affects the patient's appetite and nutritional intake; rash, which may be accompanied by itching and discomfort; loss of appetite, leading to weight loss and malnutrition; and an increased risk of COVID-19 infection, which requires patients to pay special attention to personal protection during treatment. In addition, headache is also one of the possible adverse reactions after Itovebi treatment.

In laboratory tests,Itovebi treatment may also cause a series of abnormal indicators, including neutropenia, hemoglobin decrease, fasting blood glucose increase, thrombocytopenia, lymphopenia, calcium decrease, potassium decrease, creatinine increase, ALT (alanine aminotransferase) increase, sodium decrease, magnesium decrease, etc. These anomalies require close monitoring and are handled accordingly on a case-by-case basis.

It is important to note thatItovebi treatment comes with specific warnings and precautions. Hyperglycemia, severe stomatitis, diarrhea, and embryo-fetal toxicity are areas of special concern. Therefore, when using Itovebi for treatment, doctors need to comprehensively assess the patient's physical condition, formulate a personalized treatment plan, and closely monitor the patient's condition changes.